Cargando…

Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer

Agonist CD40 monoclonal antibodies (mAb) is a promising immunotherapeutic agent for cold‐to‐hot tumor immune microenvironment (TIME) conversion. Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and lethal cancer known as an immune desert, and therefore urgently needs more effective treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hsuan‐Chen, Davila Gonzalez, Daniel, Viswanath, Dixita Ishani, Vander Pol, Robin Shae, Saunders, Shani Zakiya, Di Trani, Nicola, Xu, Yitian, Zheng, Junjun, Chen, Shu‐Hsia, Chua, Corrine Ying Xuan, Grattoni, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037694/ https://www.ncbi.nlm.nih.gov/pubmed/36658712 http://dx.doi.org/10.1002/advs.202206873

Ejemplares similares

Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer (Adv. Sci. 9/2023)
por: Liu, Hsuan‐Chen, et al.
Publicado: (2023)

Intratumoral nanofluidic system enhanced tumor biodistribution of PD‐L1 antibody in triple‐negative breast cancer
por: Liu, Hsuan‐Chen, et al.
Publicado: (2023)

Advanced strategies to thwart foreign body response to implantable devices
por: Capuani, Simone, et al.
Publicado: (2022)

Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
por: Moertel, Christopher, et al.
Publicado: (2013)

Effects of Surface Protein Adsorption on the Distribution and Retention of Intratumorally Administered Gold Nanoparticles
por: Terracciano, Rossana, et al.
Publicado: (2021)

Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
por: Zhou, Yan, et al.
Publicado: (2020)

Hyaluronate-Thiol Passivation Enhances Gold Nanoparticle Peritumoral Distribution When Administered Intratumorally in Lung Cancer
por: Terracciano, Rossana, et al.
Publicado: (2021)

Zonal Intratumoral Delivery of Nanoparticles Guided by Surface Functionalization
por: Terracciano, Rossana, et al.
Publicado: (2022)

Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020)

Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma
por: Uckun, Fatih M.
Publicado: (2021)

Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients
por: Jie, H-B, et al.
Publicado: (2013)

Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats
por: Paez-Mayorga, Jesus, et al.
Publicado: (2022)

The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer
por: Zou, Yutian, et al.
Publicado: (2022)

Author Correction: Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
por: Zhou, Yan, et al.
Publicado: (2021)

Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma
por: Salaroglio, Iris Chiara, et al.
Publicado: (2014)

Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells
por: Li, Linheng, et al.
Publicado: (2023)

Trial watch: intratumoral immunotherapy
por: Humeau, Juliette, et al.
Publicado: (2021)

Intratumoral immunosuppression profiles in 11q‐deleted neuroblastomas provide new potential therapeutic targets
por: Coronado, Esther, et al.
Publicado: (2021)

Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma
por: Weng, Jialei, et al.
Publicado: (2023)

Silicon Nanofluidic Membrane for Electrostatic Control of Drugs and Analytes Elution
por: Di Trani, Nicola, et al.
Publicado: (2020)

Pyrvinium pamoate can overcome artemisinin’s resistance in anaplastic thyroid cancer
por: Li, Yitian
Publicado: (2021)

Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2022)

New strategies for melanoma immunotherapy: How to overcome immunosuppression in the tumor microenvironment
por: Umansky, Viktor
Publicado: (2012)

Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer
por: Bazhin, Alexandr V, et al.
Publicado: (2013)

Lenalidomide overcomes the immunosuppression of regulatory CD8(+)CD28(−) T-cells
por: Neuber, Brigitte, et al.
Publicado: (2017)

Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors
por: Cao, Shuting, et al.
Publicado: (2022)

Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
por: Franson, Andrea, et al.
Publicado: (2022)

Localization of drug biodistribution in a 3D-bioengineered subcutaneous neovascularized microenvironment
por: Capuani, Simone, et al.
Publicado: (2022)

Intratumoral FoxP3(+)Helios(+) Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer
por: Syed Khaja, Azharuddin Sajid, et al.
Publicado: (2017)

Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8(+)T Cell Immunity
por: Domvri, Kalliopi, et al.
Publicado: (2022)

Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
por: Miyazaki, Tsubasa, et al.
Publicado: (2020)

Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
por: Jin, Seung Mo, et al.
Publicado: (2021)

An oncolytic virus–delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment
por: DePeaux, Kristin, et al.
Publicado: (2023)

Dendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cells
por: Berk, Erik, et al.
Publicado: (2014)

Improved Anti-Tumour Adaptive Immunity Can Overcome the Melanoma Immunosuppressive Tumour Microenvironment
por: Dang, Nana, et al.
Publicado: (2019)

Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
por: Nishiwaki, Noriyuki, et al.
Publicado: (2023)

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumor cell PD-L1 expression and intratumoral immunosuppression
por: Chen, Limo, et al.
Publicado: (2014)

Activated autologous dendritic cells injected intratumorally are able to overcome local and systemic immune suppression imposed by the tumor and its microenvironment
por: Subbiah, Vivek, et al.
Publicado: (2014)

Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
por: Martinez-Marti, A, et al.
Publicado: (2017)

Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
por: Salaroglio, Iris C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kn59uscfirg7at0g6aq0tq7sg6